Family history of alcohol dependence and initial antidepressant response to an N-methyl-D-aspartate antagonist - Wikidata - awgldk - TriplyDB

Family history of alcohol dependence and initial antidepressant response to an N-methyl-D-aspartate antagonist

Family history of alcohol dependence and initial antidepressant response to an N-methyl-D-aspartate antagonist

http://www.wikidata.org/entity/Q37307000

about

Antidepressant effects of ketamine: mechanisms underlying fast-acting novel antidepressants Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults Replication of ketamine's antidepressant efficacy in bipolar depression: a randomized controlled add-on trial Treatment-Resistant Major Depression: Rationale for NMDA Receptors as Targets and Nitrous Oxide as Therapy Pharmacological approaches to the challenge of treatment-resistant depression Glial abnormalities in substance use disorders and depression: does shared glutamatergic dysfunction contribute to comorbidity?Developing biomarkers in mood disorders research through the use of rapid-acting antidepressants Targeting the glutamatergic system to treat major depressive disorder: rationale and progress to date Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy Emerging targets for antidepressant therapies Ketamine decreases resting state functional network connectivity in healthy subjects: implications for antidepressant drug action Time-dependent metabolomic profiling of Ketamine drug action reveals hippocampal pathway alterations and biomarker candidates Using an experimental medicine model to understand the antidepressant potential of the N-Methyl-D-aspartic acid (NMDA) receptor antagonist memantine Glutamate and its receptors in the pathophysiology and treatment of major depressive disorder The Subjective Response to Nitrous Oxide is a Potential Pharmaco-Endophenotype for Alcohol Use Disorder: A Preliminary Study with Heavy Drinkers Experimental medication treatment approaches for depression.Anterior cingulate desynchronization and functional connectivity with the amygdala during a working memory task predict rapid antidepressant response to ketamine.Effects of striatal ΔFosB overexpression and ketamine on social defeat stress-induced anhedonia in mice.Glutamate receptor antagonists as fast-acting therapeutic alternatives for the treatment of depression: ketamine and other compounds.Glutamatergic modulators: the future of treating mood disorders?Ketamine and rapid-acting antidepressants: a window into a new neurobiology for mood disorder therapeutics The role of ketamine in treatment-resistant depression: a systematic review.Rapid resolution of suicidal ideation after a single infusion of an N-methyl-D-aspartate antagonist in patients with treatment-resistant major depressive disorder Ketamine and other N-methyl-D-aspartate receptor antagonists in the treatment of depression: a perspective review.Rapid antidepressant effect of ketamine in the electroconvulsive therapy setting.Serial infusions of low-dose ketamine for major depression.Proof of concept trials in bipolar disorder and major depressive disorder: a translational perspective in the search for improved treatments.Ketamine and the next generation of antidepressants with a rapid onset of action Ketamine's antidepressant efficacy is extended for at least four weeks in subjects with a family history of an alcohol use disorder.Ketamine for the treatment of depression in patients receiving hospice care: a retrospective medical record review of thirty-one cases Clinical predictors of ketamine response in treatment-resistant major depression.Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression.Ketamine as a promising prototype for a new generation of rapid-acting antidepressants.Tobacco use in bipolar disorder Advances in the Management of Treatment-Resistant Depression Novel glutamatergic agents for major depressive disorder and bipolar disorder.Biomarkers in mood disorders research: developing new and improved therapeutics.Translating glutamate: from pathophysiology to treatment.Rapid Antidepressant Response with Ketamine: Is it the Solution to Resistant Depression?Antidepressant-like effects of low ketamine dose is associated with increased hippocampal AMPA/NMDA receptor density ratio in female Wistar-Kyoto rats

P2860

Q21129276-6267CB01-26B7-4F1D-B881-45DD0946EDCB Q22252957-DFCB7A4D-FF29-4E86-9D7B-4E2347455E1A Q24629398-B4F880E2-F2E0-4CC0-8D8C-00F8C907FEEE Q26773084-C0D0CFFB-A906-4F2F-9FA1-1B4C12944547 Q26798241-A9C40BC6-9B97-4178-9F0E-792C7B5A566A Q26829556-09709796-5BC9-48B7-BA45-52BEB2572743 Q26996955-B79BBCD3-7CD2-4D8B-8D11-D8536B8CA646 Q27004490-A477F587-4016-4BD5-8717-5E1C99A0E4F0 Q27024227-D1153832-2E91-4286-B763-7AD2BB17CEE6 Q28247614-5B2347AC-0307-4BB2-9FC1-3EF1E41A0F54 Q28484157-19C876EF-178B-4449-8B64-3492055802DE Q30423149-E2F13D67-352B-49AE-9579-80829ABB417E Q30458884-35F7DB71-7BCD-4F3F-83F5-6F7A833FFE0A Q30711088-6D9A36F1-BB05-48EB-B46E-0AD94B0FFA7F Q33614487-96EA0C93-7EE6-4759-961B-61CB2B7A11CC Q33635577-A66C710E-239B-4F5E-BA9E-3DA0AE1E8705 Q33848833-F989F81A-E17B-496E-89C8-F495D5C903E5 Q33864745-F3989977-5078-4650-8617-0FD705A93129 Q33874459-7AA4D9F7-4707-4552-A4D5-06D0F34E6D03 Q34398007-6CC28826-AD30-47A7-9815-196C70A6D6A9 Q34444632-A9CB7BC4-1CE0-4EF6-B83D-156262D006F4 Q34449588-B919B455-06D6-403E-9481-C6B7036E8FA2 Q34451408-5FF50F37-9A91-4CBD-8A7D-2BFF5B407904 Q34475595-0675E391-13B0-418C-9F4C-35E080E36D65 Q34640986-90F202A8-C29F-4726-8858-797E4F10E911 Q34648663-B6B29169-C23F-477A-9C60-4BD9E94C9A38 Q34766451-68E3E0C2-98C3-4B61-AD0D-4D1DC3212AC7 Q34978041-5682A1FC-414E-4A22-A99F-31686ADF65B9 Q35001345-25380CB5-E451-4C5E-BE97-25FE552F5980 Q35020147-A4FC5160-B14E-4D7D-8566-47A4AFFC57F5 Q35026766-E2A338B5-DF3B-43FF-A8F7-E65EEE5EC6B8 Q35150163-5E20479D-847F-49C6-A133-34581D0C846B Q35547495-183444DA-9403-4C0D-8107-53D3CAFC9519 Q35579231-532668FF-FAD1-4087-8403-13C2AE7B0160 Q35580600-9CC4BA61-2A4B-4873-BFD0-F268A7D30517 Q35661119-D251586E-7778-47C9-90A2-5B946F2AC3F9 Q35735694-CFEAABD5-8E85-4651-8495-B0C6F32BF06B Q35739457-212651EC-F829-4445-B277-37A7C0B09F37 Q35993160-65B2F3DA-DB19-4261-A2C8-C906B2A02AAF Q36007530-E16F3528-3DBE-4B6A-9DD9-0E640F06E393

P2860

Family history of alcohol dependence and initial antidepressant response to an N-methyl-D-aspartate antagonist

http://www.wikidata.org/entity/Q37307000

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年学术文章

@wuu

2008年学术文章

@zh-cn

2008年学术文章

@zh-hans

2008年学术文章

@zh-my

2008年学术文章

@zh-sg

2008年學術文章

@yue

2008年學術文章

@zh

2008年學術文章

@zh-hant

name

Family history of alcohol depe ...... -methyl-D-aspartate antagonist

@en

Family history of alcohol depe ...... methyl-D-aspartate antagonist.

@nl

type

label

Family history of alcohol depe ...... -methyl-D-aspartate antagonist

@en

Family history of alcohol depe ...... methyl-D-aspartate antagonist.

@nl

prefLabel

Family history of alcohol depe ...... -methyl-D-aspartate antagonist

@en

Family history of alcohol depe ...... methyl-D-aspartate antagonist.

@nl

P1433

Q37307000-AFFECA81-1D21-40D2-8030-D76D940D14B8

P1476

Q37307000-0C28E632-56CD-4471-9918-37C2A6C6CE6A

P2093

Q37307000-2657B178-3756-4873-AB66-66642B203B0D

Q37307000-3ECB885D-2D17-4BE3-B466-82CD71531E3D

Q37307000-BC1D9536-8714-48ED-9BF4-5EDD4911BDCD

Q37307000-C2B991D5-9829-41A9-ACD9-C049D2B84383

Q37307000-E98B20F7-5FD6-4870-87FF-C07FEC82DE36

Q37307000-ECEA5792-BFEE-4C10-BCFC-4406A727C0B4

P2860

Q37307000-1F844269-F5A2-45E8-92B4-D15CB0993BC8

Q37307000-2236A82B-9C02-4464-8582-60074C420D5C

Q37307000-340E4A64-6970-4DAA-ADC3-242D971D6AF2

Q37307000-3772B397-EBD5-42AA-BC00-ECA220FC90A0

Q37307000-4F8210D9-ADDA-4DE6-868B-AF381E504ECA

Q37307000-5D6C89CC-ECD1-4BB6-8A68-210798DA4DDB

Q37307000-70323DAB-AB0D-4D51-A131-19C1412CFD74

Q37307000-79702B2F-AD8B-4530-ACD3-1384F5828CDD

Q37307000-8981E459-7FB2-466D-BE20-077A4655691F

Q37307000-9557A99F-24D0-448B-9612-CEB9F08510B4

P304

Q37307000-8F88BF56-C0A2-47A4-871E-DCD566D8DCFD

P31

Q37307000-A516B6BC-4726-4F59-9B93-3D2714D535D3

P356

Q37307000-036B3741-505D-426A-9FA7-B09FB4C5D4CB

P407

Q37307000-2C9C6291-1D49-416D-BFD3-ECF0C8C9CC94

P433

Q37307000-8E6E0AB3-7483-47C5-859A-201340B62A05

P478

Q37307000-FDB7A893-BA32-4257-AD06-923245503A57

P577

Q37307000-0E27D22B-95D8-4D55-B033-E192B23B8845

P5875

Q37307000-70FE5AE4-8D62-4DB9-8A12-18A93C1AB8A1

P698

Q37307000-564F71F3-0125-4E54-B1AF-55CB98EE4C12

P932

Q37307000-EAC8E7DF-8064-49E2-B3F1-F06B04D34044

P356

J.BIOPSYCH.2008.09.029

P1433

Biological Psychiatry

P1476

Family history of alcohol depe ...... -methyl-D-aspartate antagonist

@en

P2093

Carlos A Zarate

http://www.w3.org/2001/XMLSchema#string

David A Luckenbaugh

http://www.w3.org/2001/XMLSchema#string

Husseini K Manji

http://www.w3.org/2001/XMLSchema#string

Jazmin R Moral

http://www.w3.org/2001/XMLSchema#string

Laura E Phelps

http://www.w3.org/2001/XMLSchema#string

Nancy Brutsche

http://www.w3.org/2001/XMLSchema#string

P2860

A rating scale for depression

A new depression scale designed to be sensitive to change

Antidepressant effects of ketamine in depressed patients

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

Clinical studies implementing glutamate neurotransmission in mood disorders.

Familial relationship between mood disorders and alcoholism.

Altered NMDA glutamate receptor antagonist response in individuals with a family vulnerability to alcoholism.

NMDA receptor antagonism and the ethanol intoxication signal: from alcoholism risk to pharmacotherapy.

Psychological effects of ketamine in healthy volunteers. Phenomenological study.

The glutamatergic basis of human alcoholism.

P304

181-184

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BIOPSYCH.2008.09.029

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

65

http://www.w3.org/2001/XMLSchema#string

P577

2008-11-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23461047

http://www.w3.org/2001/XMLSchema#string

P698

18996507

http://www.w3.org/2001/XMLSchema#string

P932

2727595

http://www.w3.org/2001/XMLSchema#string